Intra-articular use of a medical device composed of hyaluronic acid and chondroitin sulfate (Structovial CS): effects on clinical, ultrasonographic and biological parameters

BMC Research Notes

Thierry Appelboom¹  Pierre Bruel²  Jean-Philippe Hauzeur¹  Yves Henrotin³ 

[1] Department of Rheumatology, Erasme Hospital, University of Brussels, 808 Route de Lennik, 1070, Brussels, Belgium;Laboratoires Pierre Fabre, 29 Avenue du Sidobre, 81 106, Castres Cedex, France;Physical Therapy and Rehabilitation Department, Princess Paola Hospital, Vivalia, Marche-en-Famenne, Bone and Cartilage Research Unit, University of Liège Institute of Pathology, level 5, CHU Sart-Tilman, 4000, Liège, Belgium

关键词: Biomarkers;    Ultrasonography;    Osteoarthritis treatment;    Clinical trial;    Knee osteoarthritis;    Hyaluronic acid;    Chondroitin sulphate;   

Others  :  1166007
DOI  :  10.1186/1756-0500-5-407

 received in 2012-04-20, accepted in 2012-07-28,  发布年份 2012

【 摘 要 】

Background

This pilot open noncontrolled study was designed to assess the efficacy of intra-articular injections of a solution combining hyaluronic acid (HA) and chondroitin sulphate (CS) in the treatment of outpatients affected by knee osteoarthrosis.

Findings

Thirty patients with knee OA have been included. The primary objective was to assess clinical efficacy as measured by pain and Lequesne’s index. Secondary objectives were to assess potential effect of the treatment on ultrasound parameters, safety and biomarkers of cartilage metabolism and joint inflammation. After a selection visit (V1), the study treatment was administered 3 times on a weekly basis (V2, V3, V4). Follow-up was planned 6 (V5) and 12 weeks (V6) after the first intra-articular injection. Efficacy results showed a reduction in mean pain at V3 and V6 and in functional impairment, the most marked changes being measured at the two follow-up visits (V5 and V6). Although statistical significance was not achieved due to small sample size, a clear tendency towards improvement was detectable for ultrasound assessments as well as biomarkers. Except for a mild injection site hematoma for which the drug causal relationship could not be excluded, no adverse effect of clinical relevance was recorded during the study.

Conclusion

Although this pilot study was performed according to an open design only, the ultrasound as well as biomarkers changes strongly suggest a non-placebo effect. These preliminary results call now for a randomized controlled study to confirm the clinical relevance of the observed results.

Trial registration

#ISRCTN91883031

【 授权许可】

   
2012 Henrotin et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Conte A, de Bernardi M, Palmieri L, Lualdi P, Mautone G, Ronca G: Metabolic fate of exogenous chondroitin sulfate in man. Arzneimittelforschung 1991, 41:768-772.
• [2]Conte A, Palmieri L, Segnini D, Ronca G: Metabolic fate of partially depolymerized chondroitin sulfate administered to the rat. Drugs Exp Clin Res 1991, 17:27-33.
• [3]Conte A, Volpi N, Palmieri L, Bahous I, Ronca G: Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate. Arzneimittelforschung 1995, 45:918-925.
• [4]Palmieri L, Conte A, Giovannini L, Lualdi P, Ronca G: Metabolic fate of exogenous chondroitin sulfate in the experimental animal. Arzneimittelforschung 1990, 40:319-323.
• [5]Huskisson EC, Donnelly S: Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford) 1999, 38:602-607.
• [6]Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, Odensten M, Ryd L, Sernbo I, Suomalainen O, Tegnander A: Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 1996, 55:424-431.
• [7]Puhl W, Bernau A, Greiling H, Kopcke W, Pforringer W, Steck KJ, Zacher J, Scharf HP: Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthr Cartil 1993, 1:233-241.
• [8]Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Leeb B, Lequesne M, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Serni U, Swoboda B, Verbruggen G, Zimmerman-Gorska I, Dougados M: EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003, 62:1145-1155.
• [9]Kato Y, Mukudai Y, Okimura A, Shimazu A, Nakamura S: Effects of hyaluronic acid on the release of cartilage matrix proteoglycan and fibronectin from the cell matrix layer of chondrocyte cultures: interactions between hyaluronic acid and chondroitin sulfate glycosaminoglycan. J Rheumatol Suppl 1995, 43:158-159.
• [10]Nishimura M, Yan W, Mukudai Y, Nakamura S, Nakamasu K, Kawata M, Kawamoto T, Noshiro M, Hamada T, Kato Y: Role of chondroitin sulfate-hyaluronan interactions in the viscoelastic properties of extracellular matrices and fluids. Biochim Biophys Acta 1998, 1380:1-9.
• [11]Kellgren J, Lawrence D: Radiological assessment of osteoarthritis. Ann Rheum Dis 1957, 16:494-502.
• [12]Lequesne MG, Mery C, Samson M, Gerard P: Indexes of severity for osteoarthritis of the hip and knee. Validation--value in comparison with other assessment tests. Scand J Rheumatol Suppl 1987, 65:85-89.
• [13]Pham T, Van Der Heijde D, Lassere M, Altman RD, Anderson JJ, Bellamy N, Hochberg M, Simon L, Strand V, Woodworth T, Dougados M: Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. J Rheumatol 2003, 30:1648-1654.
• [14]Hauzeur JP, Mathy L, De Maertelaer V: Comparison between clinical evaluation and ultrasonography in detecting hydrarthrosis of the knee. J Rheumatol 1999, 26:2681-2683.
• [15]Hasegawa M, Nakoshi Y, Tsujii M, Sudo A, Masuda H, Yoshida T, Uchida A: Changes in biochemical markers and prediction of effectiveness of intra-articular hyaluronan in patients with knee osteoarthritis. Osteoarthr Cartil 2008, 16:526-529.